Emergent BioSolutions raises 2025 guidance to $835M revenue and $210M EBITDA as international MCM sales surge (NYSE:EBS)
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...